The Real-World Study of Left Atrial Appendage Closure System in China

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1800018208

Enrollment

Unknown

Registered

2018-09-05

Start date

2018-09-12

Completion date

Unknown

Last updated

2018-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

Case series:Left Atrial Appendage Closure System for percutaneous closure of the left atrial appendage

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patient aged at least 18 years at the time of enrollment, male or female; 2. Patient who meets the current indications for percutaneous closure of the left atrial appendage, and intend to implant Left Atrial Appendage Closure System; 3. Patient is willing and capable of providing informed consent to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Patient who has hemorrhagic disease and major bleeding tendency; 2. Patient who is pregnant or lactating at the time of enrollment; 3. Patient is currently enrolled in another study or registry that would directly interfere with the current study.

Design outcomes

Primary

Measure	Time frame
Primary efficacy (All stroke(ischemic and hemorrhagic stroke), CV/unexplained death, Systemic embolism);	—

Secondary

Measure	Time frame
Implantation success rate;Sealing success rate;Procedural complications, device-related;Stroke (Ischemic and Hemorrhagic stroke);Systemic embolism;CV/unexplained death;TIA;Serious adverse event, device-related;Bleeding;Life-threatening bleeding;All-cause death;	—

Countries

China

Contacts

Public ContactCongxin Huang

Renmin Hospital of Wuhan University

huangcongxin@vip.163.com+86 027-88041911-81038

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026